本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mirum Pharmaceuticals, Inc.

81.94
-4.1250-4.79%
成交量:26.95万
成交额:2,241.01万
市值:53.20亿
市盈率:-5.82
高:87.00
开:86.06
低:81.44
收:86.06
52周最高:130.00
52周最低:63.23
股本:6,493.22万
流通股本:5,641.51万
量比:0.53
换手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-14.0800
每股收益(LYR):-0.4700
净资产收益率:-702.97%
总资产收益率:-6.79%
市净率:-510.48
市盈率(LYR):-174.33

数据加载中...

2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/27

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/27

重要事件披露

Form 8-K - Current report
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/08

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report